Fabio Pammolli
Fabio Pammolli
Professor of Economics and Management, Department of Management, Economics, and Industrial
Verified email at - Homepage
Cited by
Cited by
The productivity crisis in pharmaceutical R&D
F Pammolli, L Magazzini, M Riccaboni
Nature reviews Drug discovery 10 (6), 428-438, 2011
Economic and social consequences of human mobility restrictions under COVID-19
G Bonaccorsi, F Pierri, M Cinelli, A Flori, A Galeazzi, F Porcelli, ...
Proceedings of the national academy of sciences 117 (27), 15530-15535, 2020
A comparison of US and European university-industry relations in the life sciences
J Owen-Smith, M Riccaboni, F Pammolli, WW Powell
Management science 48 (1), 24-43, 2002
Technological change and network dynamics: lessons from the pharmaceutical industry
L Orsenigo, F Pammolli, M Riccaboni
Research policy 30 (3), 485-508, 2001
Innovation and corporate growth in the evolution of the drug industry
G Bottazzi, G Dosi, M Lippi, F Pammolli, M Riccaboni
International journal of industrial organization 19 (7), 1161-1187, 2001
Reputation and impact in academic careers
AM Petersen, S Fortunato, RK Pan, K Kaski, O Penner, A Rungi, ...
Proceedings of the National Academy of Sciences 111 (43), 15316-15321, 2014
The growth of business firms: Theoretical framework and empirical evidence
D Fu, F Pammolli, SV Buldyrev, M Riccaboni, K Matia, K Yamasaki, ...
Proceedings of the National Academy of Sciences 102 (52), 18801-18806, 2005
Global competitiveness in pharmaceuticals: a European perspective
A Gambardella, L Orsenigo, F Pammolli
Persistence and uncertainty in the academic career
AM Petersen, M Riccaboni, HE Stanley, F Pammolli
Proceedings of the National Academy of Sciences 109 (14), 5213-5218, 2012
Pharmaceuticals analyzed through the lens of a sectoral innovation system
M McKelvey, L Orsenigo, F Pammolli
Sectoral systems of innovation, 157-198, 2004
A breath of fresh air? Firm type, scale, scope, and selection effects in drug development
A Arora, A Gambardella, L Magazzini, F Pammolli
Management Science 55 (10), 1638-1653, 2009
The sustainability of European health care systems: beyond income and aging
F Pammolli, M Riccaboni, L Magazzini
The European Journal of Health Economics 13, 623-634, 2012
Human mobility in response to COVID-19 in France, Italy and UK
A Galeazzi, M Cinelli, G Bonaccorsi, F Pierri, AL Schmidt, A Scala, ...
Scientific reports 11 (1), 13141, 2021
The evolution of networks of innovators within and across borders: Evidence from patent data
A Morescalchi, F Pammolli, O Penner, AM Petersen, M Riccaboni
Research Policy 44 (3), 651-668, 2015
A multi-level geographical study of Italian political elections from Twitter data
G Caldarelli, A Chessa, F Pammolli, G Pompa, M Puliga, M Riccaboni, ...
PloS one 9 (5), e95809, 2014
Dynamic competition in pharmaceuticals: patent expiry, generic penetration, and industry structure
L Magazzini, F Pammolli, M Riccaboni
The European Journal of Health Economics, formerly: HEPAC 5, 175-182, 2004
Innovation and competitiveness in European biotechnology
F Pammolli, A Allansdottir, A Bonaccorsi, A Gambardella, M Mariani, ...
Office for Official Publications of the European Communities, 2002
Medical devices competitiveness and impact on public health expenditure
F Pammolli, M Riccaboni, C Oglialoro, L Magazzini, G Baio, N Salerno
Is Europe evolving toward an integrated research area?
A Chessa, A Morescalchi, F Pammolli, O Penner, AM Petersen, ...
Science 339 (6120), 650-651, 2013
On the size distribution of business firms
J Growiec, F Pammolli, M Riccaboni, HE Stanley
Economics Letters 98 (2), 207-212, 2008
The system can't perform the operation now. Try again later.
Articles 1–20